Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefepime continuous vs intermittent infusion in sepsis
NCT00609375Phase 4Completed
- Sponsor
- Pontificia Universidad Javeriana
- Start
- Sep 2006
- Primary completion
- Dec 2007
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cefepime in sepsis and Bacteremia, sponsored by Pontificia Universidad Javeriana. Primary endpoint: Global mortality rate at 28 days. Started Sep 2006; status: completed.
02
Drugs
cefepime
03
Conditions
sepsisBacteremia
Beyond the preview
Go deeper on NCT00609375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609375.